On Monday, Geron Corp (NASDAQ: GERN) opened lower -3.85% from the last session, before settling in for the closing price of $1.82. Price fluctuations for GERN have ranged from $1.46 to $5.34 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 6535.01%. Company’s average yearly earnings per share was noted 61.35% at the time writing. With a float of $597.84 million, this company’s outstanding shares have now reached $606.39 million.
The extent of productivity of a business whose workforce counts for 229 workers is very important to gauge. In terms of profitability, gross margin is 97.97%, operating margin of -225.64%, and the pretax margin is -226.73%.
Geron Corp (GERN) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Geron Corp is 6.13%, while institutional ownership is 71.74%. The most recent insider transaction that took place on Feb 27 ’25, was worth 24,150. In this transaction EVP, Chief Legal Officer of this company bought 15,000 shares at a rate of $1.61, taking the stock ownership to the 26,682 shares. Before that another transaction happened on Feb 27 ’25, when Company’s Chairman, President and CEO bought 12,500 for $1.76, making the entire transaction worth $22,062. This insider now owns 12,500 shares in total.
Geron Corp (GERN) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 61.35% per share during the next fiscal year.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
Check out the current performance indicators for Geron Corp (GERN). In the past quarter, the stock posted a quick ratio of 5.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 14.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.27, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach 0.02 in one year’s time.
Technical Analysis of Geron Corp (GERN)
The latest stats from [Geron Corp, GERN] show that its last 5-days average volume of 13.06 million was inferior to 14.84 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 68.82%. Additionally, its Average True Range was 0.15.
During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 9.54%, which indicates a significant decrease from 56.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 70.19% in the past 14 days, which was lower than the 77.82% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.4080, while its 200-day Moving Average is $3.8121. Now, the first resistance to watch is $1.8099. This is followed by the second major resistance level at $1.8699. The third major resistance level sits at $1.9098. If the price goes on to break the first support level at $1.7100, it is likely to go to the next support level at $1.6701. The third support level lies at $1.6101 if the price breaches the second support level.
Geron Corp (NASDAQ: GERN) Key Stats
There are currently 636,904K shares outstanding in the company with a market cap of 1.11 billion. Presently, the company’s annual sales total 76,990 K according to its annual income of -174,570 K. Last quarter, the company’s sales amounted to 47,540 K and its income totaled -25,350 K.
